Cargando…

Intratympanic corticosteroids for Ménière’s disease

BACKGROUND: Ménière's disease is a condition that causes recurrent episodes of vertigo, associated with hearing loss and tinnitus. Corticosteroids are sometimes administered directly into the middle ear to treat this condition (through the tympanic membrane). The underlying cause of Ménière...

Descripción completa

Detalles Bibliográficos
Autores principales:	Webster, Katie E, Lee, Ambrose, Galbraith, Kevin, Harrington-Benton, Natasha A, Judd, Owen, Kaski, Diego, Maarsingh, Otto R, MacKeith, Samuel, Ray, Jaydip, Van Vugt, Vincent A, Westerberg, Brian, Burton, Martin J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969957/ https://www.ncbi.nlm.nih.gov/pubmed/36847608 http://dx.doi.org/10.1002/14651858.CD015245.pub2

Ejemplares similares

Intratympanic gentamicin for Ménière’s disease
por: Webster, Katie E, et al.
Publicado: (2023)

Systemic pharmacological interventions for Ménière’s disease
por: Webster, Katie E, et al.
Publicado: (2023)

Surgical interventions for Ménière’s disease
por: Lee, Ambrose, et al.
Publicado: (2023)

Positive pressure therapy for Ménière’s disease
por: Webster, Katie E, et al.
Publicado: (2023)

Lifestyle and dietary interventions for Ménière’s disease
por: Webster, Katie E, et al.
Publicado: (2023)

Pharmacological interventions for persistent postural‐perceptual dizziness (PPPD)
por: Webster, Katie E, et al.
Publicado: (2023)

Non‐pharmacological interventions for prophylaxis of vestibular migraine
por: Webster, Katie E, et al.
Publicado: (2023)

Pharmacological interventions for prophylaxis of vestibular migraine
por: Webster, Katie E, et al.
Publicado: (2023)

Pharmacological interventions for acute attacks of vestibular migraine
por: Webster, Katie E, et al.
Publicado: (2023)

Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD)
por: Webster, Katie E, et al.
Publicado: (2023)

Intratympanic corticosteroids in Ménière's disease: A mini-review
por: Patel, Mitesh
Publicado: (2017)

Consensus on intratympanic drug delivery for Menière’s disease
por: Li, Shuna, et al.
Publicado: (2022)

Editorial: Intratympanic and surgical treatment for Meniere's disease
por: Yang, Jun, et al.
Publicado: (2022)

Efficacy and Durability of Intratympanic Gentamicin Treatment for Meniere's Disease
por: Guan, Yafeng, et al.
Publicado: (2021)

Intratympanic corticosteroids for sudden sensorineural hearing loss
por: Plontke, Stefan K, et al.
Publicado: (2022)

Intratympanic gentamycine for Ménière’s disease: is there a selective vestibulotoxic effect?
por: Molnár, András, et al.
Publicado: (2020)

Quality of life after intratympanic steroid injection for Ménière's disease
por: Schenck, Annejet A., et al.
Publicado: (2022)

Effect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere’s Disease
por: Memari, Faramarz, et al.
Publicado: (2014)

Duration of symptom control following intratympanic dexamethasone injections in Meniere’s disease
por: Hilton, Aidan, et al.
Publicado: (2022)

Correction: Effect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere’s Disease
Publicado: (2014)

Intratympanic Gentamicin for Intractable Ménière's Disease – A Review and Analysis of Audiovestibular Impact
por: Yetişer, Sertaç
Publicado: (2018)

MRI With Intratympanic Gadolinium: Comparison Between Otoneurological and Radiological Investigation in Menière's Disease
por: Neri, Giampiero, et al.
Publicado: (2021)

Therapeutic Effect of Intratympanic Injection of Dexamethasone plus Hyaluronic Acid on Patients with Meniere's disease
por: Rogha, Mehrdad, et al.
Publicado: (2019)

Intratympanic Injection of Dexamethasone and Electrocochleographic Data in Cases of Definite One Sided Refractory Meniere’s Disease
por: Dabiri Satri, Sasan, et al.
Publicado: (2017)

Effectiveness of intratympanic dexamethasone for the treatment of vertigo attacks in patients with Ménière’s disease compared with betahistine pharmacotherapy
por: Molnár, András, et al.
Publicado: (2021)

One-shot, low-dosage intratympanic gentamicin for Ménière's disease: Clinical, posturographic and vestibular test findings
por: Daneshi, Ahmad, et al.
Publicado: (2014)

Use of Skull Vibration-Induced Nystagmus in the Follow-up of Patients With Ménière Disease Treated With Intratympanic Gentamicin
por: Alonso, Susana Marcos, et al.
Publicado: (2023)

Intratympanic corticosteroid for sudden hearing loss: does it really work?()()
por: Barreto, Monique Antunes de Souza Chelminski, et al.
Publicado: (2015)

Dynamic Change of VOR and Otolith Function in Intratympanic Gentamicin Treatment for Ménière's Disease: Case Report and Review of the Literature
por: Walther, L. E., et al.
Publicado: (2013)

Comparison of the diagnostic value of 3 T MRI after intratympanic injection of GBCA, electrocochleography, and the glycerol test in patients with Meniere's disease
por: Fukuoka, Hisakuni, et al.
Publicado: (2012)

Intratympanic steroids injection is effective for the treatment of drop attacks with Ménière's disease and delayed endolymphatic hydrops: A retrospective study
por: Liu, Bo, et al.
Publicado: (2016)

Efficacy of Intratympanic OTO-104 for the Treatment of Ménière's Disease: The Outcome of Three Randomized, Double-Blind, Placebo-Controlled Studies
por: Phillips, John, et al.
Publicado: (2023)

Intratympanic Sustained-Exposure Dexamethasone Thermosensitive Gel for Symptoms of Ménière's Disease: Randomized Phase 2b Safety and Efficacy Trial
por: Lambert, Paul R., et al.
Publicado: (2016)

Effects of an Intratympanic Injection of Dexamethasone Combined with Gentamicin on the Expression Level of Serum P0 Protein Antibodies in Patients with Meniere’s Disease
por: Geng, Yang, et al.
Publicado: (2020)

The Diagnostic Value of 1.5T Versus 3.0T Magnetic Resonance Imaging Intratympanic Gadolinium Inner Ear Enhancement in Patients with Meniere’s Disease
por: Han, Yonping, et al.
Publicado: (2022)

Intratympanic gentamicin treatment for Ménière’s disease: a randomized, double-blind, placebo-controlled trial on dose efficacy - results of a prematurely ended study
por: Bremer, Hendrik G, et al.
Publicado: (2014)

Low-Dose Intratympanic Gentamicin for Unilateral Ménière‘s Disease: Accuracy of Early Vestibulo-Ocular Reflex Gain Reduction in Predicting Long-Term Clinical Outcome
por: Wegmann-Vicuña, Ricardo, et al.
Publicado: (2022)

Hyperbaric Oxygen Therapy for Sudden Sensorineural Hearing Loss after Failure from Oral and Intratympanic Corticosteroid
por: Imsuwansri, Thanarath, et al.
Publicado: (2012)

Efficacy of intratympanic or postauricular subperiosteal corticosteroid injection combined with systemic corticosteroid in the treatment of sudden sensorineural hearing loss: A prospective randomized study
por: Xie, Wen, et al.
Publicado: (2023)

Endolymphatic Hydrops Detected by 3-Dimensional Fluid-Attenuated Inversion Recovery MRI following Intratympanic Injection of Gadolinium in the Asymptomatic Contralateral Ears of Patients with Unilateral Ménière’s Disease
por: Liu, Yupeng, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9mqqve1j9p1kok0vcg4as80lq6